The raise of the risk of hypertension, overweight and obesity increases cardiovascular risk through adverse effects on lipids, insulin resistance, and other cardiometabolic processes, therefore, weight reduction is recommended in hypertensive patients with overweight or obesity for control of metabolic risk factors [12,58]. This evidence concerns the gene INS and obesity disorder.